A STUDY TO COMPARE THE EFFECT OF STEROID INJECTION WITH SHOCK WAVE THERAPY IN THE TREATMENT OF HEEL PAIN IN SMS MEDICAL COLLEGE, JAIPUR.

A PROSPECTIVE RANDOMIZED INTERVENTIONAL STUDY TO COMPARE THE EFFECT OF ULTRASOUND GUIDED METHYL PREDNISOLONE ACETATE INJECTION VERSUS RADIAL EXTRACORPOREAL SHOCK WAVE THERAPY IN THE TREATMENT OF PLANTAR FASCIITIS IN SAWAI MAN SINGH MEDICAL COLLEGE, JAIPUR. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061283

Enrollment

140

Registered

2024-01-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M722- Plantar fascial fibromatosis

Interventions

Intervention1: Injection of Methylprednisolone acetate 80mg/2ml added with 2 ml 2% lidocaine: Stat dose of ultrasound guided methyl prednisolone acetate injection (80mg/2ml) along with 2ml 2% lidocain

Eligibility

Inclusion criteria

Inclusion criteria: 1. All clinically diagnosed patients of plantar fasciitis with failed conservative management presenting in the Department of Physical Medicine & Rehabilitation OPD, SMS Medical College, Jaipur 2. Age >18 years 3. Those giving signed informed consent for study 4. =3 of the VAS present at the first steps taken in the morning 5. Reproducible pain and tenderness on palpation in medial plantar surface of foot. 6. Windlass test (reproducing pain by extension of first metatarsal joint) 7. Ultrasound evaluation showing plantar fascia thickness of =4 mm.

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years 2. History of any injection to the plantar fascia or ESWT to the heel in the past 6 months 3. History of trauma, fracture or any other surgeries leading to any functional limitation of the affected foot 4. Pain related to peripheral neuropathy or ischemia 5. History of any systemic disorders or bleeding disorders or intake of anticoagulants 6. Local or systemic infection on the date of procedure. 7. Patients not giving signed informed consent for study.

Design outcomes

Primary

Measure	Time frame
1. VISUAL ANALOGUE SCALE during the last 24 hours at rest, at the first step in the morning and during daily activities. 2. THE FOOT AND ANKLE ABILITY MEASURE (FAAM) 3. ULTRASONOGRAPHIC ASSESSMENTS 4.MEDICATION INTAKE MEASURETimepoint: At 4 weeks and 8 weeks post procedure	—

Secondary

Measure	Time frame
USG assessment Pain medication intakeTimepoint: At 4 weeks and 8 weeks post procedure	—

Countries

India

Contacts

Public ContactDR AISWARYA P

SMS MEDICAL COLLEGE AND ATTACHED HOSPITALS, JAIPUR, RAJASTHAN

Kdgupta092@yahoo.in9828141092

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 5, 2026